filings.toolsItem 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes with respect to risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table provides information about the Company’s purchases of its common stock during the quarter ended September 30, 2022:
| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs**(1)** | Approximate Dollar Value that May Yet be Purchased Under the Plans or Programs**(1)** | |||||||||||||||||||
| July 1, 2022 to July 31, 2022 | 152,312 | $ | 184.95 | 152,312 | $ | 568,012,659 | |||||||||||||||||
| August 1, 2022 to August 31, 2022 | — | — | — | 568,012,659 | |||||||||||||||||||
| September 1, 2022 to September 30, 2022 | 14,121 | 199.54 | 14,121 | 565,194,924 | |||||||||||||||||||
| Total | 166,433 | $ | 186.18 | 166,433 | $ | 565,194,924 |
(1)On March 17, 2020, the Company’s Board of Directors approved an increase of $500.0 million in the authorized level of repurchases of common stock. This approval is in addition to the prior repurchase authorization of the Board of Directors of $300.0 million on December 1, 2015. These authorizations have no expiration date.
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information